Saturday 17 October 2026
Export CUPR’s income statement to Excel — free account
Cuprina Holdings (Cayman) Limited
CUPR Healthcare Medical Instruments & Supplies
Cuprina Holdings (Cayman) Limited’s revenue for fiscal 2025 (year ended December 2025) was $38,800.00, up 9.30% from fiscal 2024.
1.90
0.05
−2.56%
Follow CUPR
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Altman Z-Score |
(0.96) | — | — |
Altman Z″-Score (non-manufacturers) |
(2.57) | (32.10) | — |
P/Operating CF |
0.00 | 0.00 | — |
P/B ratio |
0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | — |
EV/Sales |
0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | — |
EV/Operating CF |
0.00 | 0.00 | — |
EV/FCF |
0.00 | 0.00 | — |
Quick Ratio |
1.08 | 0.04 | — |
Current Ratio |
2.35 | 0.27 | — |
Net Debt/EBITDA |
0.57 | (0.06) | — |
Debt/Assets |
4.38% | 12.55% | 0.00% |
Debt/Equity |
0.07 | (0.05) | — |
Asset Turnover |
0.01 | 0.06 | — |
Operating CF/Net income |
1.95 | 0.79 | — |
Capex/Depreciation |
(1.60) | (0.52) | — |
Interest Coverage |
(329.37) | (44.14) | — |
| (1,114.99%) | 0.00% | — | |
| (92.04%) | (178.86%) | — | |
ROIC |
(130.67%) | 0.00% | — |
Return on Tangible Assets |
(108.85%) | 36.07% | — |
Average Days of Receivables |
1,872.04 | 902.73 | — |
Research and Development Expense of Revenue |
454.64% | 499.72% | — |
Selling, General and Administrative Expense of Revenue |
9,221.39% | 2,900.85% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | — |
Graham Net Nets |
0.00 | 0.00 | — |
Graham Number |
0.00 | 0.00 | — |
Free Cash Flow per Share |
(2.79) | (0.41) | — |
Cash per Share |
0.95 | 0.04 | — |
Shareholders Equity per Share |
1.54 | (1.46) | — |
Interest Debt per Share |
0.00 | 0.00 | — |
Book value per Share |
1.54 | (1.46) | — |
Free Cash Flow |
(7.15) | (0.92) | — |
Working Capital |
3.28 | (3.22) | — |
Capital Expenditures |
(0.05) | (0.02) | — |
Net Current Asset Value |
3.02 | (3.34) | — |
EV/EBIT |
0.00 | 0.00 | — |
Capex to Sales |
1.17 | 0.45 | — |
| Other line items | |||
Depreciation/Fixed assets |
0.47 | 0.73 | — |
Cash ROIC |
(107.57%) | 30.50% | — |
Accounts Receivable Turnover |
0.27 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | — |
Inventory Turnover |
0.00 | 0.00 | — |
Average Days of Payables |
8.36 | 0.00 | — |
Days of Inventory on Hand |
0.00 | 12.59 | — |
Revenue per Share |
0.02 | 0.02 | — |
Operating CF per Share |
(2.77) | (0.40) | — |
Capex per Share |
(0.02) | (0.01) | — |
Average Receivables |
0.14 | — | — |
Average Assets |
3.95 | 0.64 | — |
Average Common Equity |
0.33 | — | — |
Columns are period end dates